Cumulative triglyceride-glucose-body mass index exposure and cardiovascular disease risk: findings from the Kailuan study - Report - MDSpire

Cumulative triglyceride-glucose-body mass index exposure and cardiovascular disease risk: findings from the Kailuan study

  • By

  • Peng Fu

  • Yuxian Wang

  • Kuangyi Wu

  • Huancong Zheng

  • Zegui Huang

  • Weiqiang Wu

  • Zefeng Cai

  • Ning Wang

  • Hong Zheng

  • Haixiang Zheng

  • Bo Zhang

  • Shouling Wu

  • Youren Chen

  • July 13, 2026

Share

Clinical Report: Association of Cumulative Exposure to TyG-BMI and CVD Risk

Overview

This study investigates the association between cumulative triglyceride-glucose-body mass index (TyG-BMI) exposure and cardiovascular disease (CVD) risk in a Chinese population.

Background

Cardiovascular disease (CVD) remains the leading cause of death globally, necessitating effective risk assessment strategies. Insulin resistance, a key factor in the development of type 2 diabetes, is also recognized as an independent risk factor for CVD. The triglyceride-glucose (TyG) index serves as a practical surrogate marker for insulin resistance, and its combination with body mass index (BMI) into the TyG-BMI index may enhance cardiovascular risk prediction.

Data Highlights

QuartileHazard Ratio (95% CI)
Q11.00
Q21.32 (1.18–1.49)
Q31.33 (1.18–1.49)
Q41.44 (1.29–1.62)

Key Findings

  • 3,514 incident cardiovascular events occurred during a median follow-up of 10 years.
  • The risk of CVD increased with higher cumulative TyG-BMI exposure quartiles.
  • Cox regression analysis showed hazard ratios of 1.32, 1.33, and 1.44 for Q2, Q3, and Q4 compared to Q1.
  • A significant non-linear relationship was found between cumulative TyG-BMI and CVD risk.
  • The area under the ROC curve for cumulative TyG-BMI was 0.6047, indicating modestly better performance than TyG and BMI alone.

Clinical Implications

The findings indicate a relationship between cumulative TyG-BMI exposure and CVD risk.

Conclusion

High cumulative TyG-BMI exposure is associated with an increased risk of cardiovascular disease.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Non-linear relationship between triglyceride glucose-body mass index and risk of diabetes in adults
  2. Frontiers in Cardiovascular Medicine, 2026 -- A Body shape index combined with the triglyceride-glucose index for cardiovascular risk prediction
  3. Frontiers in Cardiovascular Medicine, 2026 -- Nationwide prospective cohort study in China: the impact of cumulative modified cardiometabolic index on cardiovascular disease incidence
  4. Clinical Rheumatology — Link Between Long-Term Serum Urate Levels and the Onset of Type II Diabetes: Insights from the Kailuan Study
  5. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily
  6. The PREVENTTM equations can improve, personalize care for adults with high BP
  7. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
  8. Associations of triglyceride–glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis | Cardiovascular Diabetology | Springer Nature Link
  9. Association of the Triglyceride–Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis
  10. 26-A-16229-ACC PROGNOSTIC VALUE OF TRIGLYCERIDE-GLUCOSE INDICES FOR CARDIOVASCULAR DISEASE AND MORTALITY IN CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME STAGES 0-3: EVIDENCE FROM A META-ANALYSIS | JACC
  11. Nonlinear relationships between the triglyceride glucose-body mass index and cardiovascular disease in middle-aged and elderly women from NHANES (1999–2018) | Scientific Reports

Original Source(s)

Related Content